↓ Skip to main content

AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression

Overview of attention for article published in Frontiers in oncology, May 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression
Published in
Frontiers in oncology, May 2021
DOI 10.3389/fonc.2021.634383
Pubmed ID
Authors

Pablo Oppezzo, Marcelo Navarrete, Nicholas Chiorazzi

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 18%
Student > Ph. D. Student 5 10%
Researcher 4 8%
Student > Bachelor 2 4%
Unspecified 2 4%
Other 3 6%
Unknown 24 49%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 14%
Immunology and Microbiology 4 8%
Agricultural and Biological Sciences 3 6%
Unspecified 2 4%
Chemical Engineering 1 2%
Other 7 14%
Unknown 25 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2022.
All research outputs
#8,578,315
of 25,477,125 outputs
Outputs from Frontiers in oncology
#3,380
of 22,568 outputs
Outputs of similar age
#179,399
of 454,811 outputs
Outputs of similar age from Frontiers in oncology
#176
of 1,256 outputs
Altmetric has tracked 25,477,125 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,568 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,811 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 1,256 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.